Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| OMNICELL, INC.OMCL · Entity 4666 | Director | June 01, 2026 | June 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
OMNICELL, INC.
Report date June 01, 2026 · Filed June 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 52,198 |
Reported balance
After 2026-06-01 transaction · row 1
1 source rowRow 1 · 2026-06-01 · Grant · Acquired 4,845 · Balance 52,198 F1: Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board Member pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the one-year anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board Member pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the one-year anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2026 Filed Jun 3, 2026 20:05 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 4,845 | $0.00 | $0.00 |
DisclosureSEC source: 0001351911-26-000002 · form4-06032026_040613.xml · nonDerivative · entry 1 Seim Robin Gene · CIK 0001351911 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,198 F1 · shares: Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board Member pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the one-year anniversary of the grant date. Read SEC document |
| June 01, 2025 Filed Jun 3, 2025 20:08 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 6,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-015371 · form4-06032025_080641.xml · nonDerivative · entry 1 Seim Robin Gene · CIK 0001351911 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,353 F1 · shares: Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board Member pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the one-year anniversary of the grant date. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:25 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 6,143 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-014257 · form4-05232024_080535.xml · nonDerivative · entry 1 Seim Robin Gene · CIK 0001351911 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,525 F1 · shares: Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board Member pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the date of the Issuer's 2025 Annual Meeting of Stockholders. Read SEC document |
| May 23, 2023 Filed May 25, 2023 20:12 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 2,710 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-008800 · form4-05252023_080554.xml · nonDerivative · entry 1 Seim Robin Gene · CIK 0001351911 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,382 F1 · shares: Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board member, pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the date of the Issuer's 2024 Annual Meeting of Stockholders. Read SEC document |
| May 24, 2022 Filed May 26, 2022 20:21 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 1,623 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005688 · form4-05262022_010528.xml · nonDerivative · entry 1 Seim Robin Gene · CIK 0001351911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,672 F1 · shares: Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board member, pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the date of the Issuer's 2023 Annual Meeting of Stockholders. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 21:33 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 780 | $153.40 | $119,650.52 |
DisclosureSEC source: 0001179110-21-008091 · edgar.xml · nonDerivative · entry 5 Seim Robin Gene · CIK 0001351911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,049 F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $153.225 to $153.43. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 21:33 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 1,668 | $152.55 | $254,450.06 |
DisclosureSEC source: 0001179110-21-008091 · edgar.xml · nonDerivative · entry 4 Seim Robin Gene · CIK 0001351911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,829 F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $152.21 to $153.165. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 21:33 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 2,291 | $151.43 | $346,918.80 |
DisclosureSEC source: 0001179110-21-008091 · edgar.xml · nonDerivative · entry 3 Seim Robin Gene · CIK 0001351911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,497 F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $151.045 to $152.03. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 21:33 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 1,947 | $150.27 | $292,566.34 |
DisclosureSEC source: 0001179110-21-008091 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,788 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $150.00 to $150.985. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 25, 2021 Filed May 26, 2021 15:16 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 1,177 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-005929 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,735 F1 · shares: Grant of restricted shares in consideration of services as a Board Member. Shares shall vest in full on the date of the Company's 2022 Annual Meeting of Stockholders Read SEC document |
| January 04, 2021 Filed Jan 4, 2021 22:18 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 1,319 | $119.62 | $157,778.78 |
DisclosureSEC source: 0001179110-21-000065 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,558 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on August 17, 2020. F1 · price: The price reported in Column 4 is the exact price of $119.62. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 26, 2020 Filed May 27, 2020 15:08 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 2,349 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-006621 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,877 F1 · shares: Grant of restricted shares in consideration of services as a Board Member. Shares shall vest in full on the date of the Company's 2021 Annual Meeting of Stockholders Read SEC document |
| May 14, 2019 Filed May 15, 2019 23:19 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantStock Options NQ (Right to Buy) · Derivative | 6,381 | $0.00 Strike: $81.92 | $0.00 |
DisclosureSEC source: 0001179110-19-006114 · edgar.xml · derivative · entry 3 Seim Robin Gene · CIK 0001351911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,381 Underlying: Common Stock · 6,381 shares Expires 2029-05-13 F2 · shares: Initial Stock Option grant will vest as to 1/3 of the shares on each anniversary of the date of grant. Read SEC document |
| May 14, 2019 Filed May 15, 2019 23:19 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 1,953 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-006114 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,528 F1 · shares: Grant of restricted shares in consideration of services as a Board Member. Shares shall vest in full on the date of the Company's 2020 Annual Meeting of Stockholders. Read SEC document |
| April 24, 2019 Filed May 7, 2019 20:12 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 246 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-005642 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,575 F1 · shares: Grant of restricted shares in consideration of services as a member of the Board of Directors. Shares vest in full on the date of the Company's 2019 Annual Meeting of Stockholders. F2 · shares: This Form 4 is being filed late due to an inadvertent administrative error. Read SEC document |
| March 17, 2019 Filed Mar 20, 2019 23:00 UTC | OMNICELL, INC. OMCL · Entity 4666 | OtherCommon Stock | 41,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-004128 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,953 F1 · shares: The disposition is reported due to cancellation of the reporting person's unvested awards in connection with his retirement as an Officer. Read SEC document |
| March 11, 2019 Filed Mar 12, 2019 22:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 2,344 | $0.00 Strike: $34.02 | $0.00 |
DisclosureSEC source: 0001179110-19-003766 · edgar.xml · derivative · entry 8 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,344 shares Expires 2025-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| March 11, 2019 Filed Mar 12, 2019 22:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 5,442 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-19-003766 · edgar.xml · derivative · entry 7 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,442 shares Expires 2027-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| March 11, 2019 Filed Mar 12, 2019 22:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 7,165 | $0.00 Strike: $36.70 | $0.00 |
DisclosureSEC source: 0001179110-19-003766 · edgar.xml · derivative · entry 6 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,165 shares Expires 2028-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| March 11, 2019 Filed Mar 12, 2019 22:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 13,849 | $0.00 Strike: $44.25 | $0.00 |
DisclosureSEC source: 0001179110-19-003766 · edgar.xml · derivative · entry 5 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,849 shares Expires 2028-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| March 11, 2019 Filed Mar 12, 2019 22:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 21,504 | $83.70 | $1,799,861.15 |
DisclosureSEC source: 0001179110-19-003766 · edgar.xml · nonDerivative · entry 4 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,618 F3 · price: The price reported in Column 4 is the average price of $83.6989. The sold price range between $83.36 to $84.12. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 11, 2019 Filed Mar 12, 2019 22:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 7,296 | $83.70 | $610,667.17 |
DisclosureSEC source: 0001179110-19-003766 · edgar.xml · nonDerivative · entry 3 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,122 F2 · price: The price reported in Column 4 is the average price of $83.6989. The sold price range between $82.05 to $83.35. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 11, 2019 Filed Mar 12, 2019 22:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 28,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003766 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,418 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 00:28 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 1,129 | $84.27 | $95,140.83 |
DisclosureSEC source: 0001179110-19-003479 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,618 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| December 15, 2018 Filed Dec 17, 2018 22:45 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 2,137 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-013976 · edgar.xml · nonDerivative · entry 3 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,747 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| December 15, 2018 Filed Dec 17, 2018 22:45 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 2,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-013976 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,884 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 21:21 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 4,101 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-008718 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,020 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| June 04, 2018 Filed Jun 4, 2018 22:03 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (right to Buy) · Derivative | 4,912 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-18-007985 · edgar.xml · derivative · entry 6 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,912 Underlying: Common Stock · 4,912 shares Expires 2027-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2018 Filed Jun 4, 2018 22:03 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (right to Buy) · Derivative | 1,312 | $0.00 Strike: $36.70 | $0.00 |
DisclosureSEC source: 0001179110-18-007985 · edgar.xml · derivative · entry 5 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,312 Underlying: Common Stock · 1,312 shares Expires 2028-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2018 Filed Jun 4, 2018 22:03 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (right to Buy) · Derivative | 9,434 | $0.00 Strike: $36.70 | $0.00 |
DisclosureSEC source: 0001179110-18-007985 · edgar.xml · derivative · entry 4 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,434 Underlying: Common Stock · 9,434 shares Expires 2028-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2018 Filed Jun 4, 2018 22:03 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 15,658 | $48.00 | $751,584.00 |
DisclosureSEC source: 0001179110-18-007985 · edgar.xml · nonDerivative · entry 3 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,121 F1 · price: The price reported in Column 4 is the Exact price of $48.00. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 04, 2018 Filed Jun 4, 2018 22:03 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 15,658 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-007985 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,779 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| May 15, 2018 Filed May 16, 2018 15:01 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (right to Buy) · Derivative | 10,156 | $0.00 Strike: $34.02 | $0.00 |
DisclosureSEC source: 0001179110-18-006846 · edgar.xml · derivative · entry 5 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,156 Underlying: Common Stock · 10,156 shares Expires 2025-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2018 Filed May 16, 2018 15:01 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (right to Buy) · Derivative | 3,130 | $0.00 Strike: $25.08 | $0.00 |
DisclosureSEC source: 0001179110-18-006846 · edgar.xml · derivative · entry 4 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,130 Underlying: Common Stock · 3,130 shares Expires 2024-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2018 Filed May 16, 2018 15:01 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 13,286 | $46.48 | $617,523.98 |
DisclosureSEC source: 0001179110-18-006846 · edgar.xml · nonDerivative · entry 3 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,121 F1 · price: The price reported in Column 4 is the average price of $46.4793. The shares sold between $46.15 to $46.80. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 15, 2018 Filed May 16, 2018 15:01 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 13,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006846 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| March 06, 2018 Filed Mar 7, 2018 23:20 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 1,265 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-003803 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,121 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 17:46 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantStock Option (Right to Buy) · Derivative | 51,136 | $0.00 Strike: $44.25 | $0.00 |
DisclosureSEC source: 0001179110-18-001771 · edgar.xml · derivative · entry 4 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,136 Underlying: Common Stock · 51,136 shares Expires 2028-02-06 F2 · shares: Shares shall vest ratably over 48 month period, with a year cliff. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 17:46 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 13,067 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-001771 · edgar.xml · nonDerivative · entry 3 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,386 F3 · shares: The Performance-based restricted stock unit awards vest as to 25% of the shares on the date of the Compensation Committee meeting in 2019 when the Committee reviews the performance-based metrics and determines if they were met or not with the remaining shares vesting on a semi-annual basis over a period of thirty-six months commencing on June 15, 2019 if the Company meets certain stock performance objectives compared to the NASDAQ Healthcare Index. The actual number of performance based stock awards that vest may be 0%, 50% or 100% of the numbers reflected above, depending upon the Company's performance. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 17:46 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 11,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-001771 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,319 F1 · shares: Restricted Stock Units shall vest semiannually on 6/15 and 12/15 for a period of 4 years. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 21:24 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 2,223 | $51.75 | $115,040.25 |
DisclosureSEC source: 0001179110-17-015482 · edgar.xml · nonDerivative · entry 3 Seim Robin Gene · CIK 0001351911 · EVP, Global A & M Adherence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,794 F1 · price: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 21:24 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 2,879 | $51.75 | $148,988.25 |
DisclosureSEC source: 0001179110-17-015482 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · EVP, Global A & M Adherence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,017 F1 · price: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| September 15, 2017 Filed Sep 15, 2017 21:56 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionNon qualified option (right to buy) · Derivative | 9,870 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-17-012344 · edgar.xml · derivative · entry 4 Seim Robin Gene · CIK 0001351911 · EVP, Global A & M Adherence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,780 Underlying: Common Stock · 9,780 shares Expires 2026-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F2 · derivative.underlying_shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| September 15, 2017 Filed Sep 15, 2017 21:56 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 9,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-012344 · edgar.xml · nonDerivative · entry 3 Seim Robin Gene · CIK 0001351911 · EVP, Global A & M Adherence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2017 Filed Sep 15, 2017 21:56 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 9,780 | $48.97 | $478,965.72 |
DisclosureSEC source: 0001179110-17-012344 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · EVP, Global A & M Adherence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,116 F1 · shares: The price reported in Column 4 is the average price of $48.9740. The shares sold between $48.05 to $49.60. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 15, 2017 Filed Aug 16, 2017 22:53 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionNon qualified Option (right to buy) · Derivative | 4,011 | $0.00 Strike: $17.29 | $0.00 |
DisclosureSEC source: 0001179110-17-011574 · edgar.xml · derivative · entry 6 Seim Robin Gene · CIK 0001351911 · EVP, Global A & M Adherence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,011 Underlying: Common Stock · 4,011 shares Expires 2023-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| August 15, 2017 Filed Aug 16, 2017 22:53 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionNon qualified option (right to buy) · Derivative | 8,850 | $0.00 Strike: $25.08 | $0.00 |
DisclosureSEC source: 0001179110-17-011574 · edgar.xml · derivative · entry 5 Seim Robin Gene · CIK 0001351911 · EVP, Global A & M Adherence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,850 Underlying: Common Stock · 8,850 shares Expires 2024-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| August 15, 2017 Filed Aug 16, 2017 22:53 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 12,861 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-011574 · edgar.xml · nonDerivative · entry 4 Seim Robin Gene · CIK 0001351911 · EVP, Global A & M Adherence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2017 Filed Aug 16, 2017 22:53 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 12,861 | $50.86 | $654,061.59 |
DisclosureSEC source: 0001179110-17-011574 · edgar.xml · nonDerivative · entry 3 Seim Robin Gene · CIK 0001351911 · EVP, Global A & M Adherence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,035 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F2 · price: The price reported in Column 4 is the average price of $50.85620. The shares sold between $50.50 to $51.30. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 15, 2017 Filed Aug 16, 2017 22:53 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 2,248 | $50.90 | $114,421.40 |
DisclosureSEC source: 0001179110-17-011574 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · EVP, Global A & M Adherence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,896 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F1 · price: The price reported in Column 4 is the average price of $50.8992. The shares sold between $50.45 to $51.30. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.